141 related articles for article (PubMed ID: 11363748)
1. Immune Response and NIH begin pediatric clinical trial of Remune HIV therapy. National Institutes of Health.
J Int Assoc Physicians AIDS Care; 1996 Jul; 2(7):44. PubMed ID: 11363748
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials of HIV treatment begin in Thailand.
AIDS Wkly Plus; 1996 Apr 8-15; ():14. PubMed ID: 12320053
[TBL] [Abstract][Full Text] [Related]
3. A primer on HIV type 1-specific immune function and REMUNE.
Moss RB; Giermakowska WK; Savary JR; Theofan G; Daigle AE; Richieri SP; Jensen FC; Carlo DJ
AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S167-75. PubMed ID: 9672235
[TBL] [Abstract][Full Text] [Related]
4. Rebuilding immunity with Remune.
Whitfield L
Posit Aware; 1998; 9(3):39-40. PubMed ID: 11365486
[TBL] [Abstract][Full Text] [Related]
5. Delayed progression to AIDS in volunteers treated with long-term HIV-1 Immunogen (REMUNE) therapy in Thailand.
Chantratita W; Sukeepaisarncharoen W; Chandeying V; Kulpradist S; Israngkura Na Ayudhtaya B; Rugpao S; Sirawaraporn W; Boonshuyar C; Churdboonchart V
HIV Med; 2004 Sep; 5(5):317-25. PubMed ID: 15369506
[TBL] [Abstract][Full Text] [Related]
6. Remune trial will stop; new trials planned.
James JS
AIDS Treat News; 1999 May; (No 319):1-2. PubMed ID: 11366461
[TBL] [Abstract][Full Text] [Related]
7. New vaccine+HAART treatment trial enrolling at NIH. National Institutes of Health.
James JS
AIDS Treat News; 1998 Aug; (No 300):3-4. PubMed ID: 11365687
[TBL] [Abstract][Full Text] [Related]
8. A boost for the immune system.
TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365925
[TBL] [Abstract][Full Text] [Related]
9. The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection.
Fernández-Cruz E; Navarro J; Rodríguez-Sainz C; Gil J; Moreno S; González-Lahoz J; Carbone J
Expert Rev Vaccines; 2003 Dec; 2(6):739-52. PubMed ID: 14711358
[TBL] [Abstract][Full Text] [Related]
10. NIH to study immune system supplement in HIV-infected women.
Public Health Rep; 1994; 109(3):458-9. PubMed ID: 8190873
[No Abstract] [Full Text] [Related]
11. Rebuilding the immune system: promising new therapy uses the HIV virus itself to awaken the damaged immune system. Interview by Brian Coppedge and Dan Dawson.
Moss R
STEP Perspect; 1998; 98(2):13-6. PubMed ID: 11365540
[TBL] [Abstract][Full Text] [Related]
12. New trial starting.
Notes Undergr; 1998; (No 37):8. PubMed ID: 11365821
[TBL] [Abstract][Full Text] [Related]
13. Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.
Robinson HL; Weinhold KJ
J Infect Dis; 2006 Dec; 194(12):1625-7. PubMed ID: 17109331
[No Abstract] [Full Text] [Related]
14. Remune trial ended.
Res Initiat Treat Action; 1999 Jul; 5(3):28. PubMed ID: 11366725
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 immunogen (remune).
Newsline People AIDS Coalit N Y; 1998 Dec; ():36. PubMed ID: 11367099
[TBL] [Abstract][Full Text] [Related]
16. IL-2 study results in confusion.
TreatmentUpdate; 1999 Jul; 11(5):4-6. PubMed ID: 11366929
[TBL] [Abstract][Full Text] [Related]
17. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C
Clin Infect Dis; 2005 Feb; 40 Suppl 1():S1-84. PubMed ID: 15655768
[TBL] [Abstract][Full Text] [Related]
18. Remune. Immune Response.
Lai D; Jones T
Curr Opin Investig Drugs; 2002 Mar; 3(3):391-8. PubMed ID: 12054085
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
20. Agouron and immune response to commercialize remune immune-based treatment.
James JS
AIDS Treat News; 1998 Jun; (No 297):1. PubMed ID: 11365593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
